ProCE Banner Activity

CE / CME

Rethinking How and Why We Treat Ambulatory Patients With COVID-19 Infections

Clinical Thought

The goal of outpatient treatment of COVID-19 is to prevent hospitalizations. However, it is often difficult to know who to treat. This activity provides an expert’s commentary on rethinking how we are approaching treatment of ambulatory patients with COVID-19 infections.

Physician Assistants: maximum of 0.25 hours of AAPA Category 1 CME credits Registered Nurses: 0.25 Nursing contact hours, includes 0.25 hour of pharmacology credit

Released: April 01, 2022

Expiration: March 31, 2023

No longer available for credit.

Share

Faculty

Michael G. Ison

Michael G. Ison, MD, MS

Professor
Divisions of Infectious Diseases and Organ Transplantation
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Acknowledgement

This activity is supported by an educational grant from Gilead Sciences, Inc.

Provided by

ProCE Banner

Supporters

Gilead Sciences, Inc.

Target Audience

NPs and PAs

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Describe current and novel strategies for testing and prevention of COVID-19

  • Apply the latest recommended management strategies to the treatment of patients with COVID-19

  • Identify patients who are eligible for monoclonal antibody treatment for COVID-19

Disclosure

All faculty and planners participating in continuing education activities sponsored by Practicing Clinicians Exchange (PCE) are required to disclose all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to PCE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.

Dr Anderson (staff): previous stock ownership: Merck.

Dr Ison: consulting fees: Adagio, ADMA Biologics, AlloVir; consulting fees/fees for non-CME/CE services: Genentech; contracted research: GlaxoSmithKline, Pulmocide.

None of the members of the Planning Committee or PCE staff have any relevant relationships to disclose, except Dr Anderson as noted above.

Instructions for Credit

Participants wishing to earn CE/CME credit must:

  1. Review the content in its entirety
  2. Relate the content material to the learning objectives
  3. Complete the post-test and evaluation form

The estimated time to complete this activity is 0.25 hours.

Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of at least 100%.

Release date: April 1, 2022
Expiration date: March 31, 2023

Format

Expert Commentary

Disclaimer

The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Practicing Clinicians Exchange or any educational supporter.

Accreditation

PCE

Joint Accreditation Statement

Joint AccreditationIn support of improving patient care, Practicing Clinicians Exchange is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

ANCC Credit Designation

NP course advisor: Mary Knudtson, DNSc, NP, FAAN, University of California, Irvine, Irvine, California

Nursing contact hours: 0.25 which includes 0.25 hours of pharmacology credit

AAPA Credit Designation

Joint AccreditationPracticing Clinicians Exchange has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 CME credits. Approval is valid until March 31, 2023. PAs should only claim credit commensurate with the extent of their participation.

PA course advisor: Daniel Forsberg, PA-C, MPH, CPH, Touro College, Skokie, Illinois

IPCE Credit Designation
IPCEThis activity was planned by and for the healthcare team, and learners will receive 0.25 Interprofessional Continuing Education (IPCE) credits for learning and change.

Additional Information

Program Medium

This program has been made available online.